As part of the action “Reform of the clawback system & offsetting it with research and investment costs”, of the National Recovery and Resilience Plan “Greece 2.0”, 53 pharmaceutical investments, totaling 519,288,136.57 euros, will be implemented until the end of 2023 , according to a joint announcement by the Ministries of Finance, Development & Investments and Health.
The responsible General Secretary for Research and Innovation of the Ministry of Development and Investments, Mr. Athanasios Kyriazis, signed the relevant, approving decision for the aid that will be given through the action. Based on this, the total public expenditure amounts to 246,787,031.11 euros. The private participation of the beneficiaries amounts to 272,501,105.46 euros.
The 53 projects meet all the participation conditions and eligibility conditions. It is noted that a total of 65 aid requests, from 40 potential beneficiaries, were submitted to the State Aid Information System (SSIS).
The General Secretariat for Research and Innovation (GSIC) informs, by sending an electronic message, both the beneficiaries of the requests approved for support and the candidates whose request for support was rejected.
The action is addressed to pharmaceutical companies that are obliged to pay an amount of automatic reimbursement (clawback) of the pharmaceutical expenditure of the E.O.P.Y.Y. and the hospital pharmaceutical expenditure. It has a budget of 250,000,000 euros, it is financed by the Recovery and Resilience Fund and its implementation body is the General Directorate of the Ministry of Development and Investments.
The Minister of Development and Investments, Mr. Adonis Georgiadis, noted: “I am extremely proud that our first investment initiative, the investment clawback, at the beginning of our term three years ago, with the synergy of the Recovery Fund and the Ministry of Finance, obtains new life and creates investments in the order of more than half a billion euros that will create jobs and bring new high technology to Greece. With these kinds of tools, Greece will move forward and leave behind the misery of the past”.
The Minister of Health, Mr. Thanos Pleuris, pointed out: “The investment approach in the field of medicine, through development clawback, in addition to strengthening domestic production and research and technology through clinical trials, ensures a better service provided to the Greek patient and makes our country a pole of attraction in all areas of health”.
The responsible for the implementation of the National Recovery and Resilience Plan “Greece 2.0”, Deputy Minister of Finance, Mr. Thodoros Skylakakis, said: “Of the 53 pharmaceutical investments, which will be implemented within the framework of the “Greece 2.0″ reform action for the clawback , many new, highly skilled jobs will be created. The government continues to implement, consistently, its reform policy, with the ultimate goal of continuously improving the efficiency of the Greek economy”.
Attached in the right column “Related Files” is the approval decision granting aid to the 53 projects that will be implemented through the “Greece 2.0” clawback reform action.
Source: Capital
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
